Board Meeting26 Mar 2026, 02:26 pm
Trading Window Closure Notice for Aarey Drugs & Pharmaceuticals Ltd Insiders
AI Summary
Aarey Drugs & Pharmaceuticals Ltd has announced the closure of its trading window for insiders, designated persons, and their immediate relatives. The closure will take effect from Wednesday, April 01, 2026, until 48 hours after the declaration of the audited financial results for the fourth quarter and financial year ending March 31, 2026. The decision is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the BSE and NSE circulars. Insiders are advised not to trade in the company's securities during this period. The board meeting date for the approval of the audited financial results will be announced in due course.
Key Highlights
- Trading window closure for insiders, designated persons, and their immediate relatives
- Closure effective from April 01, 2026, until 48 hours after the announcement of audited financial results
- Compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015
- Board meeting date for approval of audited financial results to be announced later
- Insiders advised not to trade in the company's securities during the closure period
Price Impact
More from AREYDRG